12 Week Safety Trial of Flibanserin in Depressed Women Taking an SSRI or SNRI With Decreased Sexual Desire and Distress
Status:
Terminated
Trial end date:
2011-01-01
Target enrollment:
Participant gender:
Summary
The current trial will explore the safety of flibanserin in combination with Selective
Serotonin Reuptake Inhibitors or Norepinephrine Serotonin Reuptake Inhibitors in a
representative population of women with depressive and possible concurrent anxiety
symptomatology.